Publication #7453
Reference
Name
COVID-19 antivirals update
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
COMMUNICABLE DISEASES
IMMUNISATION
INFLUENZA
COVID-19
Description
Scottish Government Health and Social Care Directorates On 4 November 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) granted a conditional marketing authorisation to the first oral antiviral for COVID-19, molnupiravir (brand name: Lagevrio).
The UK Government has signed a supply agreement with Merck Sharp and Dohme (MSD) for 480,000 patient courses of molnupiravir. The first supplies are expected to be available in December.
Contact Name
Alison Strath
Contact Email
Contact Address
Scottish Government, Pharmacy and Medicines Division, St Andrew’s House, EDINBURGH EH1 3DG.
Contact Phone
Created
2021-11-09 00:00:00
Click to go back to homepage